Immunohistochemical pitfalls and the importance of glypican 3 and arginase in the diagnosis of scirrhous hepatocellular carcinoma
Gregor Krings(Cleveland Clinic), Sanjay Kakar(University of California, San Francisco), Dhanpat Jain(Yale University), Michael Torbenson(Mayo Clinic), Rageshree Ramachandran(University of California, San Francisco), Matthew M. Yeh(University of Washington), Tsung‐Teh Wu(Analatom (United States))
Cited by 91
Related Papers
<i>TERT</i> promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
|Proceedings of the National Academy of Sciences|2013|1.4k
Comprehensive analysis of normal adjacent to tumor transcriptomes
|Nature Communications|2017|663
Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer
|Nature Medicine|2016|539
Occult hepatitis B
|The Lancet Infectious Diseases|2002|527
Mutations in Sarcomere Protein Genes in Left Ventricular Noncompaction
|Circulation|2008|454